Dialysis-related amyloidosis: Late finding or hidden epidemic?

Seminars in Dialysis

Volumn 19, Issue 2, 2006, Pages 105-109

  Dember, Laura M ^a   Jaber, Bertrand L ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN;

AMYLOIDOSIS; ARTHROPATHY; ARTICLE; BONE DISEASE; CHRONIC KIDNEY FAILURE; HUMAN; METABOLISM; METHODOLOGY; RENAL REPLACEMENT THERAPY;

AMYLOIDOSIS; BETA 2-MICROGLOBULIN; BONE DISEASES; HUMANS; JOINT DISEASES; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 33645291769     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2006.00134.x     Document Type: Article

References (58)

1. Schwalbe S Holzhauer M Schaeffer J Galanski M Koch KM Floege J Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis? Kidney Int 52 1077 1083 1997
2. Harris HW Gill TJ3rd Expression of class I transplantation antigens. Transplantation 42 109 117 1986
3. Miyata T Jadoul M Kurokawa K van Ypersele de Strihou C Beta-2 microglobulin in renal disease. J Am Soc Nephrol 9 1723 1735 1998
4. Bernier GM Con rad ME Catabolism of human beta-2-microglobulin by the rat kidney. Am J Physiol 217 1359 1362 1969
5. Zaoui PM Stone WJ Hakim RM Effects of dialysis membranes on beta 2-microglobulin production and cellular expression. Kidney Int 38 962 968 1990
6. Schoels M Jahn B Hug F Deppisch R Ritz E Hansch GM Stimulation of mononuclear cells by contact with cuprophan membranes: further increase of beta 2-microglobulin synthesis by activated late complement components. Am J Kidney Dis 21 394 399 1993
7. Floege J Ketteler M Beta2-microglobulin-derived amyloidosis: an update. Kidney Int Suppl 78 S164 S171 2001
8. Leypoldt JK Kinetics of beta-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration. Semin Dial 18 401 408 2005
9. Jadoul M Garbar C Noel H Sennesael J Vanholder R Bernaert P Rorive G Hanique G van Ypersele de Strihou C Histological prevalence of beta2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int 51 1928 1932 1997
10. Jadoul M Garbar C Vanholder R Sennesael J Michel C Robert A Noel H van Ypersele de Strihou C Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients. Kidney Int 54 956 959 1998
11. Jacobson DR Pastore RD Yaghoubian R Kane I Gallo G Buck FS Buxbaum JN Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 336 466 473 1997
12. Scholefield Z Yates EA Wayne G Amour A McDowell W Turnbull JE Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase. J Cell Biol 163 97 107 2003
13. Yamaguchi I Suda H Tsuzuike N Seto K Seki M Yamaguchi Y Hasegawa K Takahashi N Yamamoto S Gejyo F Naiki H Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro. Kidney Int 64 1080 1088 2003
14. Zhu H Yu J Kindy MS Inhibition of amyloidosis using low-molecular-weight heparins. Mol Med 7 517 522 2001
15. Ancsin JB Kisilevsky R Serum amyloid A peptide interactions with glycosaminoglycans. Evaluation by affinity chromatography. Meth Mol Biol 171 449 456 2001
16. Stevens FJ Kisilevsky R Immunoglobulin light chains, glycosaminoglycans, and amyloid. Cell Mol Life Sci 57 441 449 2000
17. Homma N Gejyo F Isemura M Arakawa M Collagen-binding affinity of beta-2-microglobulin, a preprotein of hemodialysis-associated amyloidosis. Nephron 53 37 40 1989
18. Moe SM Chen NX The role of the synovium and cartilage in the pathogenesis of beta(2)-microglobulin amyloidosis. Semin Dial 14 127 130 2001
19. Giorgetti S Rossi A Mangione P Raimondi S Marini S Stoppini M Corazza A Viglino P Esposito G Cetta G Merlini G Bellotti V Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. Protein Sci 14 696 702 2005
20. Athanasou NA Kokubun S West L Sallie B Puddle B Glycosaminoglycans in intervertebral disc amyloid deposits. Eur Spine J 4 308 312 1995
21. Athanasou NA Puddle B Sallie B Highly sulphated glycosaminoglycans in articular cartilage and other tissues containing beta 2 microglobulin dialysis amyloid deposits. Nephrol Dial Transplant 10 1672 1678 1995
22. Athanasou NA West L Sallie B Puddle B Localized amyloid deposition in cartilage is glycosaminoglycans-associated. Histopathology 26 267 272 1995
23. Inoue S Kuroiwa M Ohashi K Hara M Kisilevsky R Ultrastructural organization of hemodialysis-associated beta 2-microglobulin amyloid fibrils. Kidney Int 52 1543 1549 1997
24. Hou FF Chertow GM Kay J Boyce J Lazarus JM Braatz JA Owen WF Jr. Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis. Kidney Int 51 1514 1519 1997
25. Kawano M Muramoto H Yamada M Minamoto M Araki H Koni I Mabuchi H Nonomura A Fatal cardiac beta2-microglobulin amyloidosis in patients on long-term hemodialysis. Am J Kidney Dis 31 E4 1998
26. Mogyorosi A Schubert ML Dialysis-related amyloidosis: an important cause of gastrointestinal symptoms in patients with end-stage renal disease. Gastroenterology 116 217 220 1999
27. Choi HS Heller D Picken MM Sidhu GS Kahn T Infarction of intestine with massive amyloid deposition in two patients on long-term hemodialysis. Gastroenterology 96 230 234 1989
28. Bruno MJ van Dorp WT Ferwerda J Dekker W Schut NH Colonic pseudo-obstruction due to beta2-microglobulin amyloidosis after long-term haemodialysis. Eur J Gastroenterol Hepatol 10 717 720 1998
29. Ikegaya N Kobayashi S Hishida A Kaneko E Furuhashi M Maruyama Y Colonic dilatation due to dialysis-related amyloidosis. Am J Kidney Dis 25 807 809 1995
30. Kato A Takahashi T Watanabe T Furuhashi M Maruyama Y Hishida A Psoas abscess with osteomyelitis in a patient undergoing long-term hemodialysis. Am J Nephrol 21 410 412 2001
31. Van Audenhove A Vandermarliere A Lerut E Lodewyckx T Vanrenterghem Y Maes B Beta 2 M-amyloidosis and gastrointestinal bleeding after renal transplantation. Acta Clin Belg 58 248 250 2003
32. Khan GA Lewis FI Dasgupta M Beta 2-microglobulin amyloidosis presenting as esophageal perforation in a hemodialysis patient. Am J Nephrol 17 524 527 1997
33. Dulgheru EC Balos LL Baer AN Gastrointestinal complications of beta2-microglobulin amyloidosis: a case report and review of the literature. Arthritis Rheum 53 142 145 2005
34. Suzuki M Betsuyaku T Kojima T Saito H Nishiura Y Fukasawa Y Nishimura M Kawakami Y Pleural involvement of dialysis-related amyloidosis. Intern Med 44 628 631 2005
35. Mount SL Eltabbakh GH Hardin NJ Beta-2 microglobulin amyloidosis presenting as bilateral ovarian masses: a case report and review of the literature. Am J Surg Pathol 26 130 133 2002
36. Buchholz NP Moch H Gasser TC Linke RP Thiel GT Mihatsch MJ Ureteral amyloid deposits of beta 2-microglobulin origin in both kidney recipients of 1 donor. J Urol 153 399 401 1995
37. Miyata T Nakano T Masuzawa M Katsuoka K Kamata K Beta2-microglobulin- induced cutaneous amyloidosis in a patient with long-term hemodialysis. J Dermatol 32 410 412 2005
38. Lipner HI Minkowitz S Neiderman G Louis BM Hoch BS Dialysis-related amyloidosis manifested as masses in the buttocks. South Med J 88 876 878 1995
39. Shimizu S Yasui C Yasukawa K Nakamura H Shimizu H Tsuchiya K Subcutaneous nodules on the buttocks as a manifestation of dialysis-related amyloidosis: a clinicopathological entity? Br J Dermatol 149 400 404 2003
40. Athanasou NA Ayers D Rainey AJ Oliver DO Duthie RB Joint and systemic distribution of dialysis amyloid. Q J Med 78 205 214 1991
41. Campistol JM Argiles A Dialysis-related amyloidosis: visceral involvement and protein constituents. Nephrol Dial Transplant 11 suppl 3 142 145 1996
42. Ohashi K Takagawa R Hara M Visceral organ involvement and extracellular matrix changes in beta 2-microglobulin amyloidosis - a comparative study with systemic AA and AL amyloidosis. Virchows Arch 430 479 487 1997
43. Jimenez RE Price DA Pinkus GS Owen WF Jr. Lazarus JM Kay J Turner JR Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis. Am J Surg Pathol 22 729 735 1998
44. Takayama F Miyazaki S Morita T Hirasawa Y Niwa T Dialysis-related amyloidosis of the heart in long-term hemodialysis patients. Kidney Int Suppl 78 S172 176 2001
45. Gal R Korzets A Schwartz A Rath-Wolfson L Gafter U Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature. Arch Pathol Lab Med 118 718 721 1994
46. Yan SD Zhu H Zhu A Du Golabek AH Roher A Yu J Soto C Schmidt AM Stern D Kindy M Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med 6 643 651 2000
47. Tran M Rutecki GW Sprague SM The pathogenesis of beta(2)-microglobulin- induced bone lesions in dialysis-related amyloidosis. Semin Dial 14 131 133 2001
48. Hou FF Jiang JP Guo JQ Wang GB Zhang X Stern DM Schmidt AM Owen WF Jr. Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis. J Am Soc Nephrol 13 1296 1306 2002
49. Sousa MM Du Yan S Fernandes R Guimaraes A Stern D Saraiva MJ Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci 21 7576 7586 2001
50. Brenner DA Jain M Pimentel DR Wang B Con nors LH Skinner M Apstein CS Liao R Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 94 1008 1010 2004
51. Miyata T Inagi R Iida Y Sato M Yamada N Oda O Maeda K Seo H Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Invest 93 521 528 1994
52. Iida Y Miyata T Inagi R Sugiyama S Maeda K Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophys Res Commun 201 1235 1241 1994
53. Miyata T Hori O Zhang J Yan SD Ferran L Iida Y Schmidt AM The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 98 1088 1094 1996
54. Drueke TB Extraskeletal problems and amyloid. Kidney Int Suppl 73 S89 S93 1999
55. Jaradat MI Moe SM Effect of hemodialysis membranes on beta 2-microglobulin amyloidosis. Semin Dial 14 107 112 2001
56. Leypoldt JK Cheung AK Deeter RB Goldfarb-Rumyantzev A Greene T Depner TA Kusek J Kinetics of urea and beta-microglobulin during and after short hemodialysis treatments. Kidney Int 66 1669 1676 2004
57. Raj DS Ouwendyk M Francoeur R Pierratos A Beta(2)-microglobulin kinetics in nocturnal haemodialysis. Nephrol Dial Transplant 15 58 64 2000
58. Jaber BL Zimmerman DL Teehan GS Swedko P Burns K Meyer KB Leypoldt JK Daily hemofiltration for end-stage renal disease: a feasibility and efficacy trial. Blood Purif 22 481 489 2004